1.Kollef, MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31 (suppl 4):S131–S138.
2.Kollef, MH, Sherman, G, Ward, S, Fraser, VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462–474.
3.Leibovici, L, Shraga, I, Drucker, M, Konigsberger, H, Samra, Z, Pitlik, SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379–386.
4.Weinstein, MP, Towns, ML, Quartey, SM, et al.The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584–602.
5.Vidal, F, Mensa, J, Almela, M, et al.Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes. Arch Intern Med 1996;156:2121–2126.
6.Chow, JW, Fine, MJ, Shlaes, DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585–590.
7.Richards, MJ, Edwards, JR, Culver, DH, Gaynes, RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887–892.
8.Ibrahim, EH, Sherman, G, Ward, S, Fraser, VJ, Kollef, MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146–155.
9.Richardson, DK, Phibbs, CS, Gray, JE, McCormick, MC, Workman-Daniels, K, Goldmann, DA. Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics 1993;91:969–975.
10.Richardson, DK, Gray, JE, McCormick, MC, Workman, K, Goldmann, DA. Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993;91:617–623.
11.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
12.National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000;28:429–448.
13.Baltimore, RS. Neonatal nosocomial infections. Semin Perinatol 1998; 22:25–32.
14.Beck-Sague, CM, Azimi, P, Fonseca, SN, et al.Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis J 1994;13:1110–1116.
15.Gaynes, RP, Edwards, JR, Jarvis, WR, Culver, DH, Toison, JS, Martone, WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996;98(part 1):357–361.
16.Freeman, J, Goldmann, DA, Smith, NE, Sidebottom, DG, Epstein, MF, Platt, R. Association of intravenous lipid emulsion and coagulase-nega-tive staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990;323:301–308.
17.Stoll, BJ, Gordon, T, Korones, SB, et al.Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63–71.
18.Stoll, BJ, Hansen, N, Fanaroff, AA, et al.Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347:240–247.
19.Nambiar, S, Singh, N. Change in epidemiology of health care-associated infections in a neonatal intensive care unit. Pediatr Infect Dis J 2002; 21:839–842.
20.Leibovici, L, Samra, Z, Konigsberger, H, Drucker, M, Ashkenazi, S, Pitlik, SD. Long-term survival following bacteremia or fungemia. JAMA 1995;274:807–812.
21.Jones, GR, Lowes, JA. The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. QJM 1996; 89:515–522.
22.Meyers, BR, Sherman, E, Mendelson, MH, et al.Bloodstream infections in the elderly. Am J Med 1989;86:379–384.
23.Gransden, WR, Eykyn, SJ, Phillips, I, Rowe, B. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis 1990;12:1008–1018.
24.Bryan, CS, Reynolds, KL, Brenner, ER. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983;5:629–638.
25.Ispahani, P, Pearson, NJ, Greenwood, D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. QJM 1987;63:427–440.
26.McCue, JD. Improved mortality in gram negative bacillary bacteremia. Arch Intern Med 1985;145:1212–1216.
27.Watanakunakorn, C, Jura, J. Klebsiella bacteremia: a review of 196 episodes during a decade (1980-89). Scand J Infect Dis 1991;23:399–405.
28.Kaufman, D, Boyle, R, Hazen, KC, Patrie, JT, Robinson, M, Donowitz, LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660–1666.